[Clinical and pharmacoeconomic substantiation of the modification of eradication therapy regimens for Helicobacter pylori-associated diseases].
Grinevich
V B
VB
Samedov
B Kh
BKh
Uspenskiĭ
Iu P
IuP
Gubonina
I V
IV
D000328:Adult; D004381:Duodenal Ulcer / Q000191:economics* / Q000382:microbiology / Q000628:therapy*; D005260:Female; D017048:Health Care Costs; D016481:Helicobacter Infections / Q000150:complications* / Q000191:economics / Q000628:therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged